SCHEMBL2249784

SCHEMBL2249784

C=CC(=O)N1CCC1C(=O)Nc1cc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc2cc1OC

nearest known ligand 0.75

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EGFR P00533 19/20 0.75
ERBB2 P04626 10/20 0.61
LCK P06239 2/20 0.57
RAF1 P04049 2/20 0.56
FGFR2 P21802 2/20 0.56
FLT4 P35916 2/20 0.56
KDR P35968 2/20 0.56
TEK Q02763 2/20 0.56
ABL1 P00519 1/20 0.56
RET P07949 1/20 0.56
SRC P12931 1/20 0.56
ERBB4 Q15303 1/20 0.55
FLT1 P17948 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2249394 0.96 EGFR (0.73) EGFRERBB2LCKRAF1FGFR2
SCHEMBL2247127 0.95 EGFR (0.69) EGFRERBB2LCKRAF1FGFR2
SCHEMBL2248785 0.95 EGFR (0.72) EGFRERBB2LCKRAF1FGFR2
SCHEMBL2250896 0.93 EGFR (0.66) EGFRERBB2LCKRAF1FGFR2
SCHEMBL6103166 0.93 EGFR (0.67) EGFRERBB2LCKERBB4
SCHEMBL2252625 0.92 EGFR (0.67) EGFRERBB2LCKRAF1FGFR2
SCHEMBL2250018 0.91 EGFR (0.68) EGFRERBB2LCKRAF1FGFR2
SCHEMBL2250578 0.91 EGFR (0.70) EGFRERBB2LCKRAF1FGFR2
SCHEMBL2250458 0.90 EGFR (0.66) EGFRERBB2LCKERBB4
SCHEMBL2251513 0.90 EGFR (0.69) EGFRERBB2LCKERBB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003658-B2 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof HANMI HOLDINGS CO., LTD. (KR) 2011-08-23 US claimed
US-8003658-B2 Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof HANMI HOLDINGS CO., LTD. (KR) 2011-08-23 US disclosed